NT Mobile Menu

Search form



Sudden Unexpected Death in Epilepsy

How common is SUDEP? ©Naeblys/Shutterstock

Related content: 

Recent Content

Here is a quick primer on currently available MS therapies for partners in a patient’s healthcare team and also for patients.

Here is evidence that metformin, especially at high doses and for long periods, is associated with increased risk for neurodegenerative diseases and dementia.

New findings may have an impact on reducing the epilepsy disease burden in future generations.

New studies shed light on the potential role of monoclonal antibodies in migraine prophylaxis and in Parkinson disease and on a common genetic pathway shared by PD and autoimmune diseases.

The pros and cons of discontinuing disease-modifying therapies in multiple sclerosis.

Can you answer these 3 questions on headaches?

How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?

By clicking Accept, you agree to become a member of the UBM Medica Community.